Please provide your email address to receive an email when new articles are posted on . Of 20 hospitals providing insulin algorithms, 60% stated which patients should initiate basal or nutritional ...

Bigfoot Biomedical is doing its part to ensure that the possibility of building a smarter diabetes management system is more than just an urban legend. The tech maker has purchased a new algorithm ...

The Food and Drug Administration has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with Type 1 diabetes. These two devices, along ...

There may be another leap toward an artificial pancreas thanks to new research released by Animas Corp. At the Advanced Technologies & Treatments for Diabetes Conference in February, the company, part ...

Looking to the European market, digital therapeutics company Amalgam Rx has scored an E.U. CE Mark for its insulin titration algorithm, called iSage Rx, and its white-label variants. This comes more ...

The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic turning point. The company confirms its status as a global reference partner for ...

Control of blood glucose levels in patients with type 2 diabetes decreases the risk of complications; nevertheless, this goal can be difficult to achieve. The introduction of BASAL INSULIN ANALOGUES, ...

Afrezza is a rapid-acting inhaled human insulin indicated to improve glycemic control in adults with diabetes mellitus.